Comparative Analysis of Interventions for Prevention of Dental Caries in School Children
Launched by BAHRIA UNIVERSITY · Sep 17, 2024
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Ethical Approval approved by the BUHSC ethical committee. School administrations will be approached for permission. Consent forms will be sent to the parents of the children before the data collection visit. The data collection team comprised of 06 members will visit the selected schools. A signed consent form will be taken, and verbal consent will be obtained from the children as well. The children fulfilling the inclusion criteria will be sequenced as a list. Randomization will be done through SNOSE - a sequential number of opaque sealed envelopes will be done, and the students will then ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Schoolchildren aged 6-7 years Sound 1st permanent molars Consent obtained from parents/guardians Cooperative Children
- Exclusion Criteria:
- • 1st Permanent molar has not erupted. Children with disability. Special Children (e.g. Down syndrome)
About Bahria University
Bahria University is a leading educational institution in Pakistan, dedicated to advancing knowledge and research in the fields of health sciences and clinical studies. As a clinical trial sponsor, Bahria University leverages its academic expertise and research infrastructure to facilitate innovative studies that aim to improve patient outcomes and contribute to the broader medical community. The university is committed to upholding ethical standards and regulatory compliance in all its clinical research endeavors, ensuring the highest quality and integrity in the pursuit of scientific advancement. Through collaboration with healthcare professionals and researchers, Bahria University strives to foster an environment that promotes rigorous investigation and meaningful contributions to healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karachi, Sindh, Pakistan
Patients applied
Trial Officials
Kulsoom F Rizvi, MSc
Principal Investigator
Bahria University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported